Pacira BioSciences (NASDAQ:PCRX) stock falls as the company announces plans to cut its workforce by nearly 8% due to ...

After years of investment to upgrade its manufacturing capabilities, Pacira BioSciences figures it’s time to retire a facility that has been running for more than a decade. | After years spent ...

Pacira BioSciences plans to lay off 8% of its work force as it decommissioned one of its large-scale manufacturing suites.

Pacira BioSciences, Inc. (NASDAQ: PCRX) disclosed Wednesday that it has implemented a workforce reduction at its Science Center Campus in San Diego, California.The decision follows the company’s move ...

PARSIPPANY, N.J. — Shares of Pacira Pharmaceuticals Inc. were flat in their market debut Thursday after the extended-release drugmaker priced its initial public offering well below… ...

In a bid to expand its efforts in pain management, San Diego, California-based specialty pharmaceutical company Pacira Pharmaceuticals is spending up to $220 million to acquire MyoScience, a ...

Shares of Parsippany, N.J.-based Pacira Pharmaceuticals fell more than 12 percent Tuesday after the company reported that the FDA will take three more months to review Exparel, its extended release ...

Pacira (PCRX) BioSciences announced the receipt of U.S. Patent No. 12,156,940 from the U.S. Patent and Trademark Office, the U.S. PTO. The ‘940 patent, entitled "Manufacturing of Bupivacaine ...

PARSIPPANY, N.J. — PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported a loss of $2.8 million in its first quarter. The Parsippany, New Jersey-based comp… ...

SAN DIEGO, Dec. 18 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., a leader in sustained release injectable technologies, today announced that David M. Stack has been selected as President, Chief ...

Pacira BioSciences, Inc. (NASDAQ: PCRX) disclosed Wednesday that it has implemented a workforce reduction at its Science Center Campus in San Diego, California.The decision follows the company’s ...